177 related articles for article (PubMed ID: 17727882)
1. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).
Mooney JJ; Samson JA; Hennen J; Pappalardo K; McHale N; Alpert J; Koutsos M; Schildkraut JJ
J Psychiatr Res; 2008 Jul; 42(8):605-11. PubMed ID: 17727882
[TBL] [Abstract][Full Text] [Related]
2. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
Schildkraut JJ; Mooney JJ
Am J Psychiatry; 2004 May; 161(5):909-11. PubMed ID: 15121658
[TBL] [Abstract][Full Text] [Related]
3. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
[TBL] [Abstract][Full Text] [Related]
4. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
Eisenhofer G; Finberg JP
J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
[TBL] [Abstract][Full Text] [Related]
5. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
[TBL] [Abstract][Full Text] [Related]
6. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.
Veith RC; Lewis N; Linares OA; Barnes RF; Raskind MA; Villacres EC; Murburg MM; Ashleigh EA; Castillo S; Peskind ER
Arch Gen Psychiatry; 1994 May; 51(5):411-22. PubMed ID: 8179465
[TBL] [Abstract][Full Text] [Related]
7. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
Lenders JW; Kvetnansky R; Pacak K; Goldstein DS; Kopin IJ; Eisenhofer G
J Pharmacol Exp Ther; 1993 Jul; 266(1):288-93. PubMed ID: 8331563
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
Grossman F; Potter WZ
Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151
[TBL] [Abstract][Full Text] [Related]
9. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo.
Weinshenker D; White SS; Javors MA; Palmiter RD; Szot P
Brain Res; 2002 Aug; 946(2):239-46. PubMed ID: 12137927
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
[TBL] [Abstract][Full Text] [Related]
11. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.
Linnoila M; Karoum F; Rosenthal N; Potter WZ
Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.
Chalon SA; Granier LA; Vandenhende FR; Bieck PR; Bymaster FP; Joliat MJ; Hirth C; Potter WZ
Neuropsychopharmacology; 2003 Sep; 28(9):1685-93. PubMed ID: 12784100
[TBL] [Abstract][Full Text] [Related]
13. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients.
Piletz JE; Halaris AE; Chikkala D; Qu Y
J Psychiatr Res; 1996; 30(3):169-84. PubMed ID: 8884656
[TBL] [Abstract][Full Text] [Related]
14. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.
Eisenhofer G; Rundquist B; Aneman A; Friberg P; Dakak N; Kopin IJ; Jacobs MC; Lenders JW
J Clin Endocrinol Metab; 1995 Oct; 80(10):3009-17. PubMed ID: 7559889
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report.
Cutler NR; Zavadil AP; Linnoila M; Scheinin M; Rudorfer MV; Potter WZ
Biol Psychiatry; 1984 Apr; 19(4):549-56. PubMed ID: 6733174
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of neuronal and extraneuronal monoamine oxidase.
Eisenhofer G; Lenders JW; Harvey-White J; Ernst M; Zametkin A; Murphy DL; Kopin IJ
Neuropsychopharmacology; 1996 Sep; 15(3):296-301. PubMed ID: 8873113
[TBL] [Abstract][Full Text] [Related]
17. Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Liang CS; Himura Y; Kashiki M; Stevens SY
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1863-72. PubMed ID: 12384464
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine.
Zhang JM; Dix J; Langtimm-Sedlak CJ; Trusk T; Schroeder B; Hoffmann R; Strosberg AD; Winslow JW; Sieber-Blum M
J Neurobiol; 1997 Mar; 32(3):262-80. PubMed ID: 9058320
[TBL] [Abstract][Full Text] [Related]
19. Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.
Fujii T; Yamazaki T; Akiyama T; Sano S; Mori H
Cardiovasc Res; 2004 Oct; 64(1):125-31. PubMed ID: 15364620
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells.
Horvath G; Sutto Z; Torbati A; Conner GE; Salathe M; Wanner A
Am J Physiol Lung Cell Mol Physiol; 2003 Oct; 285(4):L829-37. PubMed ID: 12807698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
